Oncorus Stock

oncorus.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $140.5MM

Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of immune system to treat solid tumors.

Register To Buy and Sell Shares

For more details on financing and valuation for Oncorus, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Oncorus’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Oncorus.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Christophe Quéva Ph.D
Chief Scientific Officer
Mitchell Finer Ph.D
Founder & Executive Chairman
Theodore Ashburn Ph.D
Chief Executive Officer, President and Board Member
Eric Sullivan
Senior Vice President, Finance & Operations, Treasurer
John McCabe
Chief Financial Officer

Board Members

Cameron Wheeler Ph.D
Deerfield Management
Luke Evnin Ph.D
MPM Capital
Spencer Nam
Alon Lazarus Ph.D
Mitchell Finer Ph.D
Briggs Morrison MD
MPM Capital
Robert Kirkman MD
Theodore Ashburn Ph.D

Oncorus’ stock FAQs


Can you buy Oncorus’ stock?

Oncorus is not publicly traded on NYSE or NASDAQ in the U.S. To buy Oncorus’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Oncorus’ stock?

Yes, you can sell stock of a private company like Oncorus. Forge can help you sell your Oncorus stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Oncorus’ stock price?

Oncorus is a privately held company and therefore does not have a public stock price. However, you may access Oncorus’ private market stock price with Forge Data.

What is Oncorus’ stock ticker symbol?

Oncorus does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

John McCabe Joins Oncorus, Inc. as Chief Financial Officer

Oncorus, Inc., a viral immunotherapies company, today announced the appointment of John McCabe as Chief Financial Officer.

Xconomy: Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing

Nearly four years ago, the FDA approved a therapy that uses a virus to infect tumor cells and break them down---the first such viral therapy for treating
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.